Emilumenib succinate

N/A

Report date: 2025/06/10 17:55:08
NME

Base Information

Drug NameEmilumenib succinate
Drug Alias NameDS-1594DS-1594aDS-1594a HClDS-1594a succinateDS-1594b +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin/Histone-lysine N-methyltransferase 2A MLL inhibitors
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A